Posts by: Patricia Inacio, PhD

News

The U.S. Food and Drug Administration (FDA) has granted investigational new drug (IND) status to GKT831, allowing French pharmaceutical company Genkyotex to advance its drug to a Phase 2 clinical trial in patients with ... Read more

April 21, 2017May 12, 2017

NeuroVive’s NV556 Inhibits Liver Tumor Growth in Mice, Study Indicates

Liver cancer, News

NV556 inhibited tumor growth in mice with a liver disease known as non-alcoholic steatohepatitis, or NASH, according to a study by its maker, NeuroVive Pharmaceutical AB. The company will present the research, ... Read more